Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Moreno Luna, Laura E ^a   Arrieta, Oscar ^b,c   Garcia Leiva, Jorge ^a   Martínez, Braulio ^a   Torre, Aldo ^a   Uribe, Misael ^a   Léon Rodríguez, Eucario ^a,c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; LIVER ENZYME;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEASIBILITY STUDY; FEMALE; FIBROLAMELLAR CARCINOMA; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THROMBOSIS; TUMOR BIOPSY; TUMOR VOLUME; ADOLESCENT; BIOPSY; DISEASE FREE SURVIVAL; ENZYMOLOGY; LIVER; LIVER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; HUMANS; LIVER; LIVER NEOPLASMS; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 27744434462     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-142     Document Type: Article

References (21)

1. EL-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in United States. Hepatology 2001; 33: 62-5.
2. Edmondson HA. Differential diagnosis of tumors and tumor-like lesions of the liver in infancy and childhood. Am J Dis Child 1956; 91: 168-86.
3. Ruffin MT 4th. Fibrolamellar Hepatoma. Am J Gastroenterology 1990; 85: 577-81.
4. Farhi DC, Shikes RH, Silverberg SG. Ultrastructure of Fibrolamellar Oncocytic Hepatoma. Cancer 1982; 50: 702-9.
5. Wong LK, Link DP, Frey CF, Ruebner RH, Tesluk H, Pimstone NR. Fibrolamellar Hepatocarcinoma: Radiology, Management and Pathology. AJR Am J Roentgenol 1982; 139: 172-5.
6. Teitelbaum DH, Tuttle S, Carey LC, Clausen KP. Fibrolamellar Carcinoma of the Liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. Ann Surg 1985; 202: 36-41.
7. Berman HA, Burnham JA, Sheahan DG. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the Literature. Hum Pathol 1988; 19: 784-93.
8. Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980; 46: 372-9.
9. Lack EE, Neave C, Vawter GF. Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 1983; 52:1510-5.
10. Bralet MP, Regimbeau JM, Pineau P, Dubois S, Loas G, Degos F, Valla D, Belghiti J, Degott C, Terris B. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000; 32: 200-4.
11. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC. Fibrolamellar Hepatocellular Carcinoma in Children and Adolescents. Cancer 2003; 97: 2006-12.
12. Izumi R, Shimizu K, Kiriyama M, Hashimoto T, Urade M, Yagi M, Mizukami Y, Nonomura A, Miyazaki I. Alpha-fetoprotein production by hepatocellular carcinoma is prognostic of poor patient survival. J Surg Oncol 1992, 49: 151-5.
13. Yamashita Y, Takahashi M, Koga Y, Saito R, Nanakawa S, Hatanaka Y, Sato N, Nakashima K, Urata J, Yoshizumi K. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 1991; 67: 385-91.
14. Nakakura EK, Choti MA: Management of hepatocellular carcinoma. Oncology (Huntingt) 2000; 14: 1085-102.
15. Arrieta O, Garcia E, Guevara P, Garcia-Navarrete R, Ondarza R, Rembao D, Sotelo J. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. Cancer 2002; 94: 3210-8.
16. El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 2004; 39: 798-803.
17. Hernandez-Castillo E, Mondragon-Sanchez R, Garduno-Lopez AL, Gomez-Gomez E, Ruiz-Molina JM, Onate-Ocana LF. Hepatocellular carcinoma in youth: a comparative analysis with hepatocarcinoma in adults. Rev Gastroenterol Mex 2003; 68:94-9.
18. Dahan MH, Kastell P. Fibrolamellar hepatic carcinoma with a presentation similar to that of septic pregnancy. A case report. J Reprod Med 2002; 47:47-9.
19. Gemer O, Segal S, Zohav E. Pregnancy in a patient with fibrolamellar hepatocellular carcinoma. Arch Gynecol Obstet 1994; 255: 211-2.
20. Kroll D, Mazor M, Zirkin H, Schulman H, Glezerman M. Fibrolamellar carcinoma of the liver in pregnancy. A case report. J Reprod Med 1991; 36: 823-7.
21. Ichikawa T, Federle MP, Grazioli L, Madariaga J, Nalesnik M, Marsh W. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology. 1999; 213: 352-61.